Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
C-Max (Cerebrolysin variant) vs Oxytocin
An educational, source-based comparison of C-Max (Cerebrolysin variant) and Oxytocin — how each peptide works, what it's researched for, and what to know before going deeper.
Concentrated neuropeptide fraction for cognitive support research.
A concentrated fraction of cerebrolysin containing specific neuropeptide sequences. Research suggests enhanced delivery of neurotrophic factors supporting synaptic maintenance and neurogenesis.
- Post-stroke cognitive recovery
- Vascular cognitive impairment
- Traumatic brain injury rehabilitation
- • Not FDA-approved in the US; approved in select countries.
- • Requires medical supervision for IV administration.
A nonapeptide hormone produced in the hypothalamus and released from the posterior pituitary. Beyond its roles in labor and lactation, research examines central effects on trust, social cognition, anxiety, and pair bonding.
- Social cognition and autism-spectrum research
- Anxiety and PTSD modulation
- Pair-bonding and attachment models
- • FDA-approved (IV/IM) only for obstetric indications.
- • Intranasal/compounded use is off-label.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
FDA-approved with published clinical trial data.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| C-Max (Cerebrolysin variant) | Concentrated neuropeptide fractions in stroke rehabilitation | Neurorehabilitation and Neural Repair | 2018 | Improved functional outcomes in post-stroke patients receiving neuropeptide therapy. |
| Oxytocin | Intranasal oxytocin and social behavior: a meta-analysis | Psychoneuroendocrinology | 2017 | Mixed but significant effects across social-cognition endpoints. |
Side-effect & safety grid
- Not FDA-approved in the US; approved in select countries.
- Requires medical supervision for IV administration.
- FDA-approved (IV/IM) only for obstetric indications.
- Intranasal/compounded use is off-label.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
C-Max (Cerebrolysin variant) vs Oxytocin — Key differences
- Class: C-Max (Cerebrolysin variant) is classified as Nootropic · Neurotrophic, while Oxytocin is Neuropeptide · Social.
- Primary research focus: C-Max (Cerebrolysin variant) — post-stroke cognitive recovery; Oxytocin — social cognition and autism-spectrum research.
- Tag: Cognition vs Mood · Bonding.